Home > Financial Ratios > BETA DRUGS

BETA DRUGS
Price to Cash Earnings (PCE)

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 35.0225.6614.6516.956.20

What is the latest Price to Cash Earnings (PCE) ratio of BETA DRUGS ?

The latest Price to Cash Earnings (PCE) ratio of BETA DRUGS is 35.02 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202535.02
Mar202425.66
Mar202314.65
Mar202216.95
Mar20216.20

How is Price to Cash Earnings (PCE) of BETA DRUGS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 35.02
36.48
Mar2024 25.66
75.15
Mar2023 14.65
-13.57
Mar2022 16.95
173.39
Mar2021 6.2 -

Other Financial Ratios of BETA DRUGS


Compare Price to Cash Earnings (PCE) ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,961.8 Cr 12.7% 13.7% 46.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,471.0 Cr -0.5% 0.8% 19% Stock Analytics
DIVIS LABORATORIES ₹226,631.0 Cr 2.2% 23.1% 27.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,157.0 Cr -2.6% -1.6% 36% Stock Analytics
CIPLA ₹118,108.0 Cr 0.8% 2.5% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,578.0 Cr 2.6% -2.4% -5.6% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

12.7%

13.7%

46.4%

SENSEX

-0.4%

0.8%

-3%


You may also like the below Video Courses